Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


01.11.2021

2 Am J Respir Crit Care Med
1 Clin Infect Dis
1 Emerg Infect Dis
2 Eur Respir J
8 Int J Tuberc Lung Dis
10 PLoS One
1 Respir Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. ATRE SR, Jagtap JD, Faqih MI, Dumbare YK, et al
    Tuberculosis Pathways to Care and Transmission of Multidrug-Resistance in India.
    Am J Respir Crit Care Med. 2021 Oct 27. doi: 10.1164/rccm.202012-4333.
    PubMed         Abstract available

  2. NOURSADEGHI M, Gupta RK
    New Insights into the Limitations of Host-Transcriptional Biomarkers of Tuberculosis.
    Am J Respir Crit Care Med. 2021 Oct 27. doi: 10.1164/rccm.202109-2146.
    PubMed        


    Clin Infect Dis

  3. KUMAR GS, Pezzi C, Payton C, Mamo B, et al
    Health of Asylees Compared to Refugees in the United States Using Domestic Medical Examination Data, 2014-2016: A Cross-Sectional Analysis.
    Clin Infect Dis. 2021;73:1492-1499.
    PubMed         Abstract available


    Emerg Infect Dis

  4. AUNG HL, Nyunt WW, Fong Y, Biggs PJ, et al
    Genomic Profiling of Mycobacterium tuberculosis Strains, Myanmar.
    Emerg Infect Dis. 2021;27:2847-2855.
    PubMed         Abstract available


    Eur Respir J

  5. GUPTE AN, Kumar P, Araujo-Pereira M, Kulkarni V, et al
    Baseline IL-6 is a biomarker for unfavorable tuberculosis treatment outcomes: a multi-site discovery and validation study.
    Eur Respir J. 2021 Oct 28. pii: 13993003.00905-2021.
    PubMed         Abstract available

  6. SALUZZO F, Mantegani P, Poletti de Chaurand V, Cirillo DM, et al
    QIAreach QuantiFERON(R)-TB for the diagnosis of M. tuberculosis infection.
    Eur Respir J. 2021 Oct 21. pii: 13993003.02563-2021.
    PubMed        


    Int J Tuberc Lung Dis

  7. PURCHASE S, Batist E, Mmile N, Nkosi S, et al
    Challenges in recruiting children to a multidrug-resistant TB prevention trial.
    Int J Tuberc Lung Dis. 2021;25:814-822.
    PubMed         Abstract available

  8. OXLADE O, den Boon S, Menzies D, Falzon D, et al
    TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up.
    Int J Tuberc Lung Dis. 2021;25:823-831.
    PubMed         Abstract available

  9. BLACK M, Da Silva P, Scott L
    Rifampicin-resistant TB: discordance between Xpert((R)) MTB/RIF and MTBDRplus results.
    Int J Tuberc Lung Dis. 2021;25:832-838.
    PubMed         Abstract available

  10. EJO M, Van Deun A, Nunn A, Meredith S, et al
    Effectiveness of GenoType MTBDRsl in excluding TB drug resistance in a clinical trial.
    Int J Tuberc Lung Dis. 2021;25:839-845.
    PubMed         Abstract available

  11. TAHSEEN S, Khanzada FM, Hussain A, Akhtar N, et al
    Phenotypic vs. genotypic resistance to fluoroquinolones in rifampicin-resistant TB.
    Int J Tuberc Lung Dis. 2021;25:861-863.
    PubMed        

  12. ARENAS-MIRAS M, Sanchez-Martinez F, Jove-Caballe N, Villar-Garcia J, et al
    Clinical experience of TB in patients treated with anti-TNF-alpha.
    Int J Tuberc Lung Dis. 2021;25:866-868.
    PubMed        

  13. HASSAN L, Ali SM, Iqbal W, Baig S, et al
    Automated detection and reduction of stigma in online discussions about TB.
    Int J Tuberc Lung Dis. 2021;25:869-870.
    PubMed        

  14. SEKANDI JN, Tucker EG, Zalwango S, Buregyeya E, et al
    Digital technologies and loss to follow-up for TB patients.
    Int J Tuberc Lung Dis. 2021;25:871-872.
    PubMed        


    PLoS One

  15. YU G, Zhong F, Shen Y, Zheng H, et al
    Diagnostic accuracy of the Xpert MTB/RIF assay for tuberculous pericarditis: A protocol of systematic review and meta-analysis.
    PLoS One. 2021;16:e0252109.
    PubMed         Abstract available

  16. WITTE C, Fowler JH, Pfeiffer W, Hungerford LL, et al
    Social network analysis and whole-genome sequencing to evaluate disease transmission in a large, dynamic population: A study of avian mycobacteriosis in zoo birds.
    PLoS One. 2021;16:e0252152.
    PubMed         Abstract available

  17. JAIN J, Jadhao P, Banait S, Salunkhe P, et al
    Diagnostic accuracy of GeneXpert MTB/RIF assay for detection of tubercular pleural effusion.
    PLoS One. 2021;16:e0251618.
    PubMed         Abstract available

  18. AGGARWAL AN, Agarwal R, Dhooria S, Prasad KT, et al
    Active pulmonary tuberculosis and coronavirus disease 2019: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0259006.
    PubMed         Abstract available

  19. KASO AW, Hailu A
    Costs and cost-effectiveness of Gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia.
    PLoS One. 2021;16:e0259056.
    PubMed         Abstract available

  20. CUEVAS-CORDOBA B, Fresno C, Haase-Hernandez JI, Barbosa-Amezcua M, et al
    A bioinformatics pipeline for Mycobacterium tuberculosis sequencing that cleans contaminant reads from sputum samples.
    PLoS One. 2021;16:e0258774.
    PubMed         Abstract available

  21. FLORENTINI EA, Angulo N, Gilman RH, Alcantara R, et al
    Correction: Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis.
    PLoS One. 2021;16:e0259439.
    PubMed         Abstract available

  22. BADA FO, Blok N, Okpokoro E, Dutt S, et al
    Correction: Cost comparison of nine-month treatment regimens with 20-month standardized care for the treatment of rifampicin-resistant/multi-drug resistant tuberculosis in Nigeria.
    PLoS One. 2021;16:e0259492.
    PubMed         Abstract available

  23. MICHENI LN, Kassaza K, Kinyi H, Ntulume I, et al
    Rifampicin and isoniazid drug resistance among patients diagnosed with pulmonary tuberculosis in southwestern Uganda.
    PLoS One. 2021;16:e0259221.
    PubMed         Abstract available

  24. THOMAS BE, Thiruvengadam K, S R, Rani S, et al
    Understanding health care-seeking behaviour of the tribal population in India among those with presumptive TB symptoms.
    PLoS One. 2021;16:e0250971.
    PubMed         Abstract available


    Respir Med

  25. HAN DW, Jo KW, Kim OH, Shim TS, et al
    Cavity formation and its predictors in noncavitary nodular bronchiectatic Mycobacterium avium complex pulmonary disease.
    Respir Med. 2021;179:106340.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: